Company Close Updates Archives | Email alerts

Jan. 26, 2021, 5:07 p.m. EST

Pfizer Inc. stock underperforms Tuesday when compared to competitors despite daily gains

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Pfizer Inc. PFE inched 0.08% higher to $37.31 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.15% to 3,849.62 and Dow Jones Industrial Average DJIA falling 0.07% to 30,937.04. This was the stock's third consecutive day of gains. Pfizer Inc. closed $5.77 short of its 52-week high ($43.08), which the company achieved on December 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ rose 2.71% to $170.48, Merck & Co. Inc. MRK fell 1.11% to $80.25, and Novartis AG ADR NVS fell 2.57% to $95.94. Trading volume (27.5 M) remained 17.4 million below its 50-day average volume of 44.9 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.